Literature DB >> 25548474

Pathogenesis of alcoholic liver disease: role of oxidative metabolism.

Elisabetta Ceni1, Tommaso Mello1, Andrea Galli1.   

Abstract

Alcohol consumption is a predominant etiological factor in the pathogenesis of chronic liver diseases, resulting in fatty liver, alcoholic hepatitis, fibrosis/cirrhosis, and hepatocellular carcinoma (HCC). Although the pathogenesis of alcoholic liver disease (ALD) involves complex and still unclear biological processes, the oxidative metabolites of ethanol such as acetaldehyde and reactive oxygen species (ROS) play a preeminent role in the clinical and pathological spectrum of ALD. Ethanol oxidative metabolism influences intracellular signaling pathways and deranges the transcriptional control of several genes, leading to fat accumulation, fibrogenesis and activation of innate and adaptive immunity. Acetaldehyde is known to be toxic to the liver and alters lipid homeostasis, decreasing peroxisome proliferator-activated receptors and increasing sterol regulatory element binding protein activity via an AMP-activated protein kinase (AMPK)-dependent mechanism. AMPK activation by ROS modulates autophagy, which has an important role in removing lipid droplets. Acetaldehyde and aldehydes generated from lipid peroxidation induce collagen synthesis by their ability to form protein adducts that activate transforming-growth-factor-β-dependent and independent profibrogenic pathways in activated hepatic stellate cells (HSCs). Furthermore, activation of innate and adaptive immunity in response to ethanol metabolism plays a key role in the development and progression of ALD. Acetaldehyde alters the intestinal barrier and promote lipopolysaccharide (LPS) translocation by disrupting tight and adherent junctions in human colonic mucosa. Acetaldehyde and LPS induce Kupffer cells to release ROS and proinflammatory cytokines and chemokines that contribute to neutrophils infiltration. In addition, alcohol consumption inhibits natural killer cells that are cytotoxic to HSCs and thus have an important antifibrotic function in the liver. Ethanol metabolism may also interfere with cell-mediated adaptive immunity by impairing proteasome function in macrophages and dendritic cells, and consequently alters allogenic antigen presentation. Finally, acetaldehyde and ROS have a role in alcohol-related carcinogenesis because they can form DNA adducts that are prone to mutagenesis, and they interfere with methylation, synthesis and repair of DNA, thereby increasing HCC susceptibility.

Entities:  

Keywords:  Acetaldehyde; Alcohol metabolism; Alcoholic liver disease; CYP2E1; Hepatic stellate cells; Liver fibrosis; Protein adducts; Reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 25548474      PMCID: PMC4273126          DOI: 10.3748/wjg.v20.i47.17756

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  239 in total

1.  NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.

Authors:  Andreas Glässner; Marianne Eisenhardt; Benjamin Krämer; Christian Körner; Martin Coenen; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

2.  Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

Authors:  Lauren N Bell; Constance J Temm; Rashmil Saxena; Raj Vuppalanchi; Philip Schauer; Mordechai Rabinovitz; Alyssa Krasinskas; Naga Chalasani; Samer G Mattar
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

3.  Influence of acetaldehyde and ethanol on rat hepatic lipocyte characteristics in primary culture.

Authors:  T Sato; G R Gordon; N Murayama; R Kato; C A Tyson
Journal:  Cell Biol Int       Date:  1995-10       Impact factor: 3.612

4.  Regulation of human metabolism by hypoxia-inducible factor.

Authors:  Federico Formenti; Dumitru Constantin-Teodosiu; Yaso Emmanuel; Jane Cheeseman; Keith L Dorrington; Lindsay M Edwards; Sandy M Humphreys; Terence R J Lappin; Mary F McMullin; Christopher J McNamara; Wendy Mills; John A Murphy; David F O'Connor; Melanie J Percy; Peter J Ratcliffe; Thomas G Smith; Marilyn Treacy; Keith N Frayn; Paul L Greenhaff; Fredrik Karpe; Kieran Clarke; Peter A Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

5.  Activation by acetaldehyde of the promoter of the mouse alpha2(I) collagen gene when transfected into rat activated stellate cells.

Authors:  F A Anania; J J Potter; L Rennie-Tankersley; E Mezey
Journal:  Arch Biochem Biophys       Date:  1996-07-15       Impact factor: 4.013

Review 6.  Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.

Authors:  Nathalie Druesne-Pecollo; Bertrand Tehard; Yann Mallet; Mariette Gerber; Teresa Norat; Serge Hercberg; Paule Latino-Martel
Journal:  Lancet Oncol       Date:  2009-02       Impact factor: 41.316

7.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

8.  The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model.

Authors:  Angelica Butura; Kerstin Nilsson; Kengathevy Morgan; Timothy R Morgan; Samuel W French; Inger Johansson; Ina Schuppe-Koistinen; Magnus Ingelman-Sundberg
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

Review 9.  Neutrophilic infiltration in alcoholic hepatitis.

Authors:  Abraham P Bautista
Journal:  Alcohol       Date:  2002-05       Impact factor: 2.405

10.  The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease.

Authors:  Stéphanie Patouraux; Stéphanie Bonnafous; Cosmin S Voican; Rodolphe Anty; Marie-Christine Saint-Paul; Maria-Alessandra Rosenthal-Allieri; Hélène Agostini; Micheline Njike; Nadége Barri-Ova; Sylvie Naveau; Yannick Le Marchand-Brustel; Pascal Veillon; Paul Calès; Gabriel Perlemuter; Albert Tran; Philippe Gual
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

View more
  118 in total

1.  Upregulation of autophagy components in alcoholic hepatitis and nonalcoholic steatohepatitis.

Authors:  M Masouminia; S Samadzadeh; A S Mendoza; B A French; B Tillman; S W French
Journal:  Exp Mol Pathol       Date:  2016-07-16       Impact factor: 3.362

Review 2.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 3.  Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

Authors:  Alex Boye; Yu-Hong Zou; Yan Yang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism.

Authors:  Paul G Thomes; Karuna Rasineni; Li Yang; Terrence M Donohue; Jacy L Kubik; Mark A McNiven; Carol A Casey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-04       Impact factor: 4.052

5.  The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.

Authors:  Ying Xu; Dan Chen; Xiu-Xian Lin; Qing Zhao; Jing Guo; Li-Jie Chen; Wei Zhang; Jian Xiao; Guang-Hui Lian; Shi-Fang Peng; Dong Guo; Hong Yang; Obinna Obianom; Yan Shu; Yao Chen
Journal:  Arch Toxicol       Date:  2019-04-11       Impact factor: 5.153

Review 6.  Microbiota-based treatments in alcoholic liver disease.

Authors:  Hotaik Sung; Seung Woo Kim; Meegun Hong; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

7.  Chronic ethanol consumption disrupts diurnal rhythms of hepatic glycogen metabolism in mice.

Authors:  Uduak S Udoh; Telisha M Swain; Ashley N Filiano; Karen L Gamble; Martin E Young; Shannon M Bailey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-09       Impact factor: 4.052

8.  Quantifying Competition among Mitochondrial Protein Acylation Events Induced by Ethanol Metabolism.

Authors:  Hadi R Ali; Mohammed A Assiri; Peter S Harris; Cole R Michel; Youngho Yun; John O Marentette; Frank K Huynh; David J Orlicky; Colin T Shearn; Laura M Saba; Richard Reisdorph; Nichole Reisdorph; Matthew D Hirschey; Kristofer S Fritz
Journal:  J Proteome Res       Date:  2019-01-31       Impact factor: 4.466

Review 9.  Immune dysfunction in acute alcoholic hepatitis.

Authors:  Ashwin D Dhanda; Peter L Collins
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation.

Authors:  Jianguo Lin; Anping Chen
Journal:  Lab Invest       Date:  2016-05-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.